Introduction and hypothesis The aim of this paper is to study if xenograft reinforcement of vaginal repair reduces recurrence of prolapse. Methods Results 1-5 years after vaginal repair were studied in 41 cases with xenograft and in 82 matched controls without. Symptoms were evaluated by a validated questionnaire and anatomy by pelvic organ prolapse quantification (POPQ). Results Significant more cases, 97% versus 81% controls, felt cured or much improved (p=0.02); 11% of cases and 19% of controls had POP symptoms, POPQ>−1 was found in 31% cases and 24% controls. Defining recurrence as POPQ>−1 plus symptoms revealed recurrence in 3% of cases and 12% controls. None of the recurrence rates was significantly different for cases versus controls. No vaginal erosions were seen. Previous surgery was a significant risk factor with odds ratio 7.3 for another recurrence. Conclusions Recurrence rates defined by POPQ plus symptoms were low compared to literature. Xenograft reinforcement might improve results.
Introduction
Pelvic organ prolapse (POP) is common in parous women. The prevalence ranges from 4% to 51%, dependent on whether it is an anatomical observation or a combination of anatomical and symptomatic POP [1] [2] [3] .
Patients often present with several complaints from bladder, bowel and sexual function, but except from a vaginal bulge, no symptom is specific for POP, and evaluation of POP should include anatomy as well as function of pelvic organs.
Symptoms of pelvic floor dysfunction and anatomical defects are not very well correlated [4] [5] [6] [7] , probably because symptoms from bladder, bowel and sexual life are common in women, and coexist with POP without major causeeffect relationship.
Symptomatic POP is mostly treated surgically. Vaginal repair is one of the most commonly performed operations, yet the golden standard for neither preoperative evaluation nor for surgical technique has been established [8] .
Several studies have reported a high recurrence rate of POP after traditional vaginal repair, especially in the anterior compartment [8] . However, the definition of recurrent POP is not always clear, whether it is an anatomical recurrence in the same vaginal compartment, prolapse in another vaginal compartment or recurrence of the patient's symptoms. The differences in definitions make comparison of published studies difficult.
The high anatomical recurrence rate has promoted the use of implants in vaginal surgery [9, 10] , of which, synthetic implants carry a high risk of erosion and dyspareunia dependent on material and surgical technique. The erosion rate is reported up to 26% and de novo dyspareunia up to 38% [11] . Synthetic implants are not recommended for routine use in vaginal surgery for the time being [8] .
Allograft and xenograft are resorbable and do not have this high erosion rate. For resorbable implants, the challenge is more on the durability, i.e. if the graft will last long enough to provide sufficient scaffolding for collagen deposition and scar formation to prevent recurrence.
In studies using porcine implants, the conclusions do not agree neither regarding anatomical nor functional results [8, [12] [13] [14] [15] [16] [17] , or whether reinforcement of traditional vaginal repair is superior to just placing the xenograft over the vaginal defect without repair.
Besides the technical aspects of POP surgery, which may be important for the recurrence rate, some patient-related risk factors, such as straining at defecation, previous pelvic floor surgery, obesity, hard physical work, multiparity, chronic coughing and old age, are factors thought to increase the risk of development as well as recurrence of POP [18] [19] [20] , either because of increased abdominal pressure or weakened pelvic floor support.
The aim of this study was to evaluate the long-term anatomical and functional results of vaginal repairs with and without reinforcement with xenograft implants in a retrospective case-control study, where surgical and patient-related factors were matched. Furthermore, risk factors for recurrence of anatomical POP were analysed.
Materials and methods
This is a retrospective study, where patients, who had vaginal repairs reinforced by xenograft (Surgisis) in the period 2000-2005, were identified and chosen as "cases". Each case was matched with two "controls" operated in the same vaginal compartment, the same year and at the same age (±5 years). The patients were identified from the hospitals database of ICD-10 codes and surgical codes before they were invited for follow-up (FU).
Patient files were used to record preoperative symptoms, pelvic examination, details of surgery, previous surgery and major perioperative complications.
Anterior repair was done by plication of the pubocervical fascia with 2-0 polyglactin sutures, and posterior repair as sitespecific, when a well-defined defect was found or in most cases as a plication of the rectovaginal fascia. Vault prolapse was repaired by vaginal uterosacral suspension, in some cases preceded by vaginal hysterectomy, described in [21] .
In cases, where Surgisis was used in either the anterior or posterior repair, a four-layer 4×7 cm implant was placed over the repair and sutured by 2-0 polyglactin to the vaginal fascia. Surgisis is prepared from porcine small intestine submucosa. It is acellular and consists of non-cross-linked collagen and extracellular matrix containing growth factors. Surgisis is degraded in 12 weeks and acts as a scaffold for host connective tissue.
The patients were contacted for FU 1-5 years after surgery. They filled in a validated 16-item questionnaire concerning POP symptoms (i.e. feeling a lump at or outside the introitus) and bladder, bowel and sexual symptoms [4] . For each symptom, the patient filled in a bother score, recording if the symptom was a severe, moderate, small or no problem. The questionnaire included a question, asking if the patient felt her symptoms were cured, improved, unchanged or worse. Furthermore, they answered six questions concerning suspected risk factors for recurrence of POP: parity, largest birth weight, obstetric anal sphincter tear, chronic coughing, oestrogen treatment and body weight.
The patient was recorded symptomatic, when she had a symptom at least once per week as opposed to asymptomatic, when she had this symptom less than once per month or never.
The anatomical outcome was measured by POP quantification (POPQ). Anatomical POP was considered present, when the most dependent vaginal point was ≥ −1 cm from the hymen, corresponding to ≥ stage 2 prolapse. Surgical recurrence was defined as ≥ stage 2 prolapse in the operated vaginal compartment, and de novo POP was defined as ≥ stage 2 POP in a "new" not-operated compartment.
Data from cases were compared to controls. Primary outcome parameters were POPQ and symptoms from the questionnaire, analysed by test of independence by χ 2 -tables and Fisher's exact test, when appropriate. When data were missing in a case, both her controls were excluded in the analyses of this parameter.
Suspected risk factors for recurrent anatomical prolapse in the operated vaginal compartment, i.e. women with POPQ≥−1 versus no recurrence, were analysed using logistic regression.
The study was approved by the Ethical Committee of Copenhagen.
Results
Forty-one cases and 82 controls were identified. The mean age at surgery was 65 years (44-86); the median FU was 3 years, i.e. 24%: 4-5 years, 30%: 3 years, 40%: 2 years and 6%: 1 year.
Preoperatively, all patients felt a lump at or outside the introitus and had ≥ stage 2 POP. Cases and controls were matched for age, operated vaginal compartment and length of FU. Comparison of the non-matched preoperative symptoms and risk factors in cases versus controls are shown in Table 1 . For these data, there were no significant intergroup differences.
Primary versus secondary vaginal repair was a factor that could not be matched prior to the study, because there is no code for recurrent prolapse in the International Classification of Diseases. From the patient files, we found that 24 cases (59%) versus 18 controls (22%) had recurrent prolapse in the same compartment, and that 18 cases (43%) versus ten controls (12%) had had repair of a prolapse in another compartment before this index operation. Significantly, more controls (p<0.05) were primary repairs.
Anterior repair was done in 15 cases and their corresponding 30 controls; posterior repair was done in 26 cases (+52 controls). In 11 cases (+22 controls), the repair was combined with uterosacral suspension.
Ten different surgeons performed the operations; some were senior registrars under supervision. One control was reoperated within 24 h because of bleeding, no other perioperative complications were seen.
At the 1-5 years FU, 110 questionnaires (94%=110/123) and 95 POPQ (77%=95/123) measurements could be analysed. The 13 missing questionnaires were explained by two cases had died (+4 controls excluded) and seven were reoperated in the FU period. Eight cases were interviewed by telephone, because they lived far away or were too old and fragile to attend the FU, and the questionnaire was filled in by the interviewer.
Seven patients (two cases and five controls) were reoperated, two cases and two controls for POP, two controls with tension-free vaginal tape (TVT), and one was operated for ovarian cancer. The two reoperated cases both had posterior repairs with Surgisis at the index operation and were reoperated with anterior repairs. The two reoperated controls had surgical recurrences in the posterior compartment and were analysed as surgical recurrences.
There was no difference in preoperative data for participants versus non-participants for FU.
According to the questionnaire, significantly more cases (p=0.02) felt subjectively cured or much improved of their prolapse symptoms, i.e. 37 cases (97%) versus 59 controls (81%).
The functional symptoms recorded in the 110 questionnaires are displayed in Table 2 .
Ninety percent (33/35) of cases and 80% (58/73) of controls did not feel a lump anymore.
Of the 29 patients with incontinence at least once per week, four cases and 12 controls complained of stress incontinence, two cases and one control of urge incontinence, and two cases and eight controls of mixed incontinence. In four cases (16%) and five controls (9%), the incontinence was de novo. Two controls were operated with TVT in the FU period.
Seven cases and ten controls complained of bladder emptying problems, only three of them had residuals >100 ml.
Constipation was a problem at least once a week for 16% of cases and 23% of controls. Ten cases and 17 controls had faecal evacuation problems.
In the 45 sexually active women, two thirds of both cases and controls had coitus less than once per week; 90% were satisfied with the frequency. Three (3/13=23%) cases and 12 (12/32=37%) controls had dyspareunia or felt vaginal dryness. None complained of leakage during coitus. All 15 patients complaining of dyspareunia had normal dimensions of their vagina at POPQ.
In the 65 sexually inactive women, the reason for inactivity was dyspareunia in three, urinary leakage in two, and lack of partner or partner's impotence in 42.
No significant differences in numbers with bladder, bowel or sexual symptoms were found, when comparing cases versus controls, anterior versus posterior repairs or patients with versus without anatomical POP.
The POPQ stage at FU is displayed in Tables 3 and 4 . Three cases and nine controls had surgical recurrence after anterior repair with Ba≥−1, and seven cases and six controls after posterior repair with Bp≥−1. There was no significant difference between numbers with surgical recurrence in cases versus controls or in anterior versus posterior repairs.
De novo POP developed in the anterior compartment in seven cases and 17 controls, and in the posterior compartment in no cases and nine controls. As seen from Table 4 , more controls seemed to develop de novo POP, but the difference was not significant (p=0.07).
When the POPQ stage 2 was further broken down, 36% had Ba/Bp=−1, 54% had Ba/Bp=0 and only 10% had Ba/Bp=+1.
Comparing functional symptoms to anatomical prolapse in any compartment (Table 5 ) revealed that only 27% (12/44) with POPQ ≥ stage 2 could feel a lump at or outside the introitus at least once per week. Significantly, more controls, ten versus two cases (p<0.05) with POP ≥ stage 2, felt symptoms of a lump.
No case had symptomatic surgical recurrence in the anterior compartment, and only one case had symptomatic recurrence in the posterior compartment. All in all, the symptomatic surgical recurrence rate in cases reinforced by Surgisis implant was 3%.
Two controls had surgical recurrence with symptoms in the anterior compartment, and four (+2 reoperated patients) in the posterior compartment, the overall symptomatic surgical recurrence rate was 12% for controls, but the recurrence rate did not differ significantly between cases and controls (p=0.23 with Fishers exact test).
Recurrence of prolapse by different definitions is displayed in Fig. 1 . Surgical recurrence, defined as Ba/Bp≥−1 (stage 2) in the operated vaginal compartment, was found in ten cases (31%), 3/15 anterior and 7/26 posterior repairs, and in 15 controls (24%), 9/30 anterior and 6/52 posterior repairs.
Four cases (11%) and 14 controls (19%) had symptoms of a lump at or outside the introitus ≥ once per week. Symptomatic patients would include both women with de novo and surgical recurrent POP and even women with ≤ stage 1 POP.
When using the same definition of recurrent POP as preoperatively, where the indication for surgery was symptoms plus ≥ stage 2 prolapse, only one case (3%) and eight controls (12%) had symptomatic surgical recurrence. The one case and one control found their symptom was a minor problem, while two controls were reoperated, and three recorded moderate problems and two severe problems on the bother score. Analyses of risk factors for surgical recurrence were done in logistic regression models. Neither overweight, chronic coughing, constipation, nor obstetric factors as multiparity, high birth weight, anal sphincter rupture, oestrogen use, surgery in anterior versus posterior compartment nor surgery in more than one compartment versus a single compartment were significant risk factors for recurrent prolapse ≥ stage 2 in the operated compartment.
The only significant risk factor found was previous vaginal repair in the same compartment, which had an odds ratio 7.3 for a second recurrence.
Discussion
This study illustrates how results vary with definition of POP. Patients were operated, when they had symptoms of a lump at or outside the introitus and ≥ stage 2 prolapse. When using the same definition, 3% of cases and 12% of controls had recurrent symptomatic prolapse in the operated vaginal compartment. The difference was not statistically significant but showed a trend towards better results using xenograft reinforcement, especially considering the increased risk of a second recurrent prolapse by a factor 7 in patients with previous vaginal repair, which was the case for 59% of cases compared to 22% of controls. This study was an FU study, which means that implant reinforcement was chosen by the surgeon in patients with inferior tissue quality judged during surgery.
Defining recurrence as patients reporting symptoms of a lump at or outside the introitus at least once per week revealed 11% of cases and 19% of controls were symptomatic. Usually, patients cannot feel if a lump is from the anterior or posterior vaginal wall, from a recurrent prolapse or a "new" prolapse. The high number of de novo POP in the controls, as well as the fact that 37% of controls compared to 11% of cases felt a lump, when their POPQ stage was ≥2, could explain that significantly more cases, 97% versus 81% controls, felt cured or much improved. Another contributing factor could be higher expectations in cases, knowing they got an implant.
Our subjective cure rate was better than in other studies with 90% of cases and 80% of controls not having symptoms of a lump. In Hawkins' as well as Tegerstedts' studies [3, 22] , the subjective cure rate after 4 and 10 years FU was 59% and 46%, respectively. In the first study [22] , the most successful surgeon had 77% cured and the least 45%. Most patients had combined surgery. Patients were more satisfied after surgery if they were older, operated by a particular team and did not have a concomitant colposuspension. In our study, ten different surgeons operated, but the procedure for vaginal repair was specified and uniform, as the department is a teaching unit. Furthermore, vaginal repair was not combined with incontinence surgery. Longer FU would probably increase our recurrence rate as seen in the life table analysis in the study of Shull et al. [21] .
Defining recurrence by POPQ ≥−1 at the operated vaginal compartment revealed recurrence in 31% of cases and 24% of controls and de novo prolapse in 32% of cases and 41% of controls. No recurrence or new prolapse was higher than stage 2. Anatomical recurrence rates around 33%, especially in the anterior compartment, are typical and reproduced in this study. Adding "new" prolapse in the notoperated compartment gives close to 50% of patients having stage 2 prolapse in one or more compartments. The same high numbers with stage 2 POP were seen in the prevalence study of asymptomatic women by Swift [1] . POPQ staging cannot be used as the only criteria for recurrence of POP, since anatomy does not explain patients' symptoms or satisfaction after surgery.
All in all, about half of the patients, cases as well as controls, had anatomical stage 2 prolapse in one or two vaginal compartments, but only 10% had POPQ with Ba/Bp=+1, which was comparable to the symptomatic numbers. Other studies also found the same sparse symptoms using stage 2 as the cut-off for anatomical prolapse [1, 5, 23, 24] . In the study of Barber [25] , only 10% felt a lump with Ba/Bp= −1, 45% with Ba/Bp=0 and 100% with Ba/Bp≥+1. Stage 2, ranging from −1 to +1, seems to be an insensitive cut-off for anatomical POP in relation to patient's symptoms. In this study, two patients were reoperated because of recurrent POP; this is consistent with other studies [3, [21] [22] [23] [24] . Five of the seven patients with symptomatic recurrent prolapse reported moderate or severe problems because of the lump; still, they did not attend for reoperation. What is important for patients seeking treatment for POP and for their satisfaction with treatment is relatively unknown. In the study by Elkadry et al. [26] , satisfaction with surgery was not related to objective cure, defined as POPQ stage 0 or 1. Dissatisfaction was related to postoperative complications from incontinence and sexual dysfunction.
The high anatomical recurrence rate after vaginal repair has been attributed to defective and low content of collagen in the pubocervical and rectovaginal fascia [27] . Reinforcement with Surgisis might increase tissue strength and prevent failure, since non-cross linked collagen acts as a scaffold for collagen disposition. On the other hand, if defect collagen is genetic and not caused by the prolapse, the new tissue will have the same weakness. This theory is supported in the comparative study of Surgisis implants by Chaliha et al. [12] , where 14 women had their anterior vaginal repair reinforced with four layers of Surgisis. After 6 months FU, both subjective and anatomical results were superior in the Surgisis group compared to 14 controls operated with traditional repair, but the difference was not seen after 2 years.
In a study of implants in a rabbit model [28] , Surgisis was replaced with a thin fibrotic layer within 60 days with minimal foreign body reaction and few erosions compared to Pelvicol and Prolene implants. After 2 years, there was no difference in strength between the three materials. Pelvicol and Prolene implants tended to brake at the interface with host tissue, while Surgisis broke inside the implant. Our problem is that we know too little about the aetiology of primary as well as recurrent prolapse to make clinically relevant conclusions from animal studies.
Pelvicol has been studied more extensively. In a randomised study by Meschia et al. [29] , the anatomical recurrence rate in the Pelvicol reinforced group was 7% compared to 19% in the traditional anterior repair group after 1 year. There was only one case of vaginal extrusion of the implant. Posterior repair with Pelvicol reinforcement was less successful, with 46% anatomical failure rate compared to 22% after traditional repair after 1 year [15] . In Altman's study of 33 patients [16] , Pelvicol was placed over the posterior defect without any vaginal repair. After 1 year, anatomical recurrence was seen in 39%. Recurrence of POP could be explained both by the type of graft but also by the surgical technique. Graft reinforcement might give a better result than covering the defect with a graft without repair.
In our study no erosion, infection or shrinkage of the implant was seen, which is in accordance with other studies of resorbable implants. The procedure is safe, does no harm, and there is a trend that Surgisis reinforcement improves anatomical and functional results compared to traditional vaginal repair. This is in opposition to synthetic implants that give an acceptable anatomical result in the short term, but carry the risk of erosion, shrinkage and dyspareunia as well as more serious complications with infection and nerve lesions, that is hardly ever seen after traditional vaginal repairs [8] [9] [10] [11] .
Our registration of the preoperative symptoms was incomplete. Some symptoms were probably underregistrated because of their intimate nature not brought forward if not specifically asked for. Because of the more systematic registration of symptoms at FU, more patients might actually be cured from symptoms than was found in this study.
Furthermore, POPQ was not used routinely in our department, when these patients were operated. Our staging system is equivalent to POPQ staging, but staging alone may under-registrate smaller stage 1 prolapses in the less affected vaginal compartments.
Another limitation of this retrospective study is the significant baseline difference in the number of previous vaginal surgeries in the same vaginal compartment in the 2 groups of 59% versus 22% and in the other compartment in 43% versus 12%. This difference has to be taken into account, when the results are the same in the two groups, but previous surgery increases the risk of a second or more recurrence with a factor 7. A risk factor present two to three times as often in the xenograft group.
In conclusion, as the symptomatic and anatomical outcome is better or the same with Surgisis reinforcement compared to traditional vaginal repairs, even in patients with high risk of recurrence, and seeing very few complications, it indicates a possible benefit of using Surgisis. This can only be studied in a prospective randomised study, which is in progress.
Using an anatomical definition of prolapse as ≥ stage 2 overestimated the number of patients with recurrent prolapse. Defining recurrence by the same means as the indication for surgery, i.e. symptoms plus ≥ stage 2 prolapse, revealed low recurrence rates, compared to literature.
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